Drug Discovery in the Age of COVID-19

Researchers worldwide are racing to find effective vaccine and drug candidates to inhibit infection with and replication of SARS-CoV-2, the virus that causes COVID-19. Using NVIDIA GPUs, they’re accelerating this lengthy discovery process — whether for structure-based drug design, molecular docking, generative AI models, virtual screening or high-throughput screening.